Finance

Lists
HYPE3:BVMF
Hypera SA
R$26,93
0,00%
(0,00) 1D
9 ຕ.ລ., 17 ໂມງ 5 ນາທີ 47 ວິນາທີ GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for HYPE3...
Open
R$26,96
High
R$27,25
Low
R$26,51
Mkt. cap
18,96 ຕື້
Avg. vol.
3,90 ລ້ານ
Volume
0,00
Dividend
3,56%
Quarterly dividend
R$0,24
Ex-dividend date
9 ກ.ພ. 2026
P/E ratio
10,14
52-wk high
R$30,00
52-wk low
R$19,43
EPS
R$2,66
Shares outstanding
704,01 ລ້ານ
No. of employees
11 ພັນ
Open
R$26,96
High
R$27,25
Low
R$26,51
Mkt. cap
18,96 ຕື້
Avg. vol.
3,90 ລ້ານ
Volume
0,00
Dividend
3,56%
Quarterly dividend
R$0,24
Ex-dividend date
9 ກ.ພ. 2026
P/E ratio
10,14
52-wk high
R$30,00
52-wk low
R$19,43
EPS
R$2,66
Shares outstanding
704,01 ລ້ານ
No. of employees
11 ພັນ
News stories
From web sources and news partners
StreetInsider
StreetInsider
·
2 ນາທີກ່ອນ
Scinai signs $5.1M CDMO deal with Nasdaq-listed biopharma
CNBC
CNBC
·
17 ນາທີກ່ອນ
S&P 500 futures are mixed ahead of bank earnings
marketscreener.com
marketscreener.com
·
25 ນາທີກ່ອນ
Chips off the table
Profile
Hypera Pharma is a Brazilian multinational pharmaceutical company and is the largest Brazilian pharmaceutical company by market capitalization. Headquartered in São Paulo, its business include pharmaceuticals, consumer healthcare and cosmetics products, and biotechnology products. Wikipedia
About Hypera SA
CEO-
Employees10,6 ພັນ
Founded2001
HeadquartersItaim Bibi, ລັດ ເຊົາ ເປົາໂລ, ບະເລຊີນ
SectorPharmaceutical industry
Last report
7 ສ.ຫ. 2026
Fiscal period
Q2 2026
R$0,70 / R$0,70
-0,54%miss
Revenue / Est. (BRL)
2,34 ຕື້ / 2,33 ຕື້
+0,28%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in BRL
Loading Previous Earnings...
Revenue
Net income
All values in BRL
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
2,23 ຕື້
2,24 ຕື້
2,02 ຕື້
2,34 ຕື້
Cost of goods sold
865,21 ລ້ານ
858,94 ລ້ານ
807,22 ລ້ານ
892,99 ລ້ານ
Cost of revenue
865,21 ລ້ານ
858,94 ລ້ານ
807,22 ລ້ານ
892,99 ລ້ານ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
687,46 ລ້ານ
728,46 ລ້ານ
703,28 ລ້ານ
780,69 ລ້ານ
Operating expense
688,45 ລ້ານ
728,74 ລ້ານ
701,06 ລ້ານ
773,84 ລ້ານ
Total operating expenses
1,55 ຕື້
1,59 ຕື້
1,51 ຕື້
1,67 ຕື້
Operating income
673,59 ລ້ານ
649,38 ລ້ານ
509,50 ລ້ານ
669,87 ລ້ານ
Other non operating income
-14,67 ລ້ານ
-27,28 ລ້ານ
-8,73 ລ້ານ
-30,17 ລ້ານ
EBT including unusual items
448,11 ລ້ານ
439,21 ລ້ານ
276,14 ລ້ານ
492,29 ລ້ານ
EBT excluding unusual items
452,42 ລ້ານ
438,30 ລ້ານ
279,75 ລ້ານ
488,66 ລ້ານ
Income tax expense
-5,77 ລ້ານ
-10,46 ລ້ານ
-69,54 ລ້ານ
2,28 ລ້ານ
Effective tax rate
-1,29%
-2,38%
-25,18%
0,46%
Other operating expenses
987,00 ພັນ
283,00 ພັນ
-2,21 ລ້ານ
-6,84 ລ້ານ
Net income
457,64 ລ້ານ
450,99 ລ້ານ
347,38 ລ້ານ
490,24 ລ້ານ
Net profit margin
20,55%
20,16%
17,22%
20,98%
Earnings per share
0,72
0,71
0,55
0,70
Interest and investment income
69,23 ລ້ານ
68,87 ລ້ານ
64,66 ລ້ານ
63,02 ລ້ານ
Interest expense
-283,65 ລ້ານ
-268,84 ລ້ານ
-282,34 ລ້ານ
-209,57 ລ້ານ
Net interest expenses
-214,42 ລ້ານ
-199,97 ລ້ານ
-217,68 ລ້ານ
-146,55 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
728,99 ລ້ານ
702,34 ລ້ານ
562,68 ລ້ານ
755,79 ລ້ານ
Gain or loss from assets sale
-11,00 ພັນ
-253,00 ພັນ
-3,20 ລ້ານ
-698,00 ພັນ
AI content may include mistakes. Learn more
ແອັບຂອງ Google